Mini-consolidations or intermediate-dose cytarabine (IDAC) for the post-remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries.
Pretransplantation risk factors for MRD after allogeneic stem cell transplantation in AML patients: A prospective study
Reduced Intensity transplantation vs chemotherapy. A prospective, pseudorandomized study in 50-70 year old AML patients
Isocitrate Dehydrogenase (IDH) 1 and 2 Mutations Predicts Better Outcome in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation: a study of the ALWP of the EBMT
Imatinib with intensive chemotherapy in AML with t(9;22)(q34.1;q11.2)/BCR::ABL1. A DATAML registry study.
Improved Prevention and Treatment Strategies for Differentiation Syndrome Contribute to Reducing Early Mortality in Patients With Acute Promyelocytic Leukemia
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203
Hu8F4-CAR T cells with mutated Fc spacer segment improve target-specificity and mediate anti-leukemia activity in vivo
Haploidentical vs Mismatched Unrelated Donor Transplants with Posttransplant Cyclophosphamide-based GVHD Prophylaxis
NOL10 is required for NUP98-DDX10 leukemia